How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

580 results for

Barlows Test

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Barlow's Test

Barlow's Test Barlows Test Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Barlow's Test Barlow's Test Aka: Barlow's Test , Barlow (...) Test , Barlow Maneuver II. Indication evaluation III. Mechanism Attempt to sublux unstable hip Perform with caution Examine each hip individually IV. Preparation Infant lying supine with diaper off Hips flexed to 90 degrees V. Technique Stabilize Place index and middle finger over greater trochanter Place thumb medially at inner thigh inguinal crease Gently adduct the hip while applying downward force VI. Findings Positive if felt on exam Represents dislocation of hip out of acetabulum Positive

2018 FP Notebook

2. On the efficacy of the Barlow Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: a systematic review and meta-analysis

On the efficacy of the Barlow Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne (...) applicable, Holm-Bonferroni correction for testing multiple subgroup analyses will be performed. If one or more subgroup analyses cannot be performed due to insufficient data, the p-value will be adjusted accordingly. ">Other Subgroup analysis or meta-regression are used to explore between-study heterogeneity and can provide insight into the relationship between study characteristics (e.g. species, sex or drug class or dose) and effect size. They should be considered hypothesis-generating. Ideally

2019 PROSPERO

3. AIM Clinical Appropriateness Guidelines for Molecular Testing of Solid and Hematologic Tumors and Malignancies

AIM Clinical Appropriateness Guidelines for Molecular Testing of Solid and Hematologic Tumors and Malignancies Appropriate.Safe.Affordable © 2019 AIM Specialty Health 2066-0319b Clinical Appropriateness Guidelines Molecular Testing of Solid and Hematologic Tumors and Malignancies EFFECTIVE MARCH 31, 2019 PROPRIETARY Guidelines developed by, and used with permission from, Informed Medical Decisions, Inc. © 2019 Informed Medical Decisions, Inc. All Rights Reserved. 2 Table of Contents Appropriate (...) Essential Thrombocythemia or Thrombocytosis 13 Primary Myelofibrosis 13 Solid Tumor Testing 13 Breast Cancer 13 Lung Cancer 15 Cell-Free Tumor Testing 16 Cancer of Unknown Primary/Occult Neoplasm 17 Prostate Cancer 17 Thyroid Cancer 18 Cancer Screening 18 Indeterminate Thyroid Nodules 18 Colorectal Cancer Screening 20 Professional Society Guidelines 21 Selected References 23 Revision History 26 PROPRIETARY Guidelines developed by, and used with permission from, Informed Medical Decisions, Inc. © 2019

2019 AIM Specialty Health

4. C-reactive protein point-of-care testing

C-reactive protein point-of-care testing 80 1 Health technology description Key points ? Evidence from randomised controlled trials indicates that, for adults with symptoms of lower respiratory tract infection (LRTI) presenting in primary care, C-reactive protein (CRP) point-of- care testing (POCT) can reduce antibiotic use where there is clinical uncertainty around the benefit of prescribing. In trials, this reduction is attained without negative impact on rates of recovery or re-consultation (...) are subject to peer review. Evidence notes do not make recommendations for NHSScotland, however the Scottish Health Technologies Group (SHTG) produces an Advice Statement to accompany all evidence reviews. What is the clinical and cost-effectiveness of C-reactive protein point-of-care testing to guide antibiotic prescribing in patients presenting to primary care with symptoms of lower respiratory tract infection? Number 80 May 2018 In response to an enquiry from The Scottish Antimicrobial Prescribing

2018 Evidence Notes from Healthcare Improvement Scotland

5. HTA of C-reactive protein point-of-care testing to guide antibiotic prescribing

HTA of C-reactive protein point-of-care testing to guide antibiotic prescribing Health Technology Assessment (HTA) of CRP POCT Health Information and Quality Authority i Health Technology Assessment of C-reactive protein point-of-care testing to guide antibiotic prescribing for acute respiratory tract infections in primary care settings April 2019 Health Technology Assessment (HTA) of CRP POCT Health Information and Quality Authority ii Health Technology Assessment (HTA) of CRP POCT Health (...) and inappropriate consumption of antibiotics. Most antibiotics are prescribed in primary care settings and frequently to treat respiratory tract infections, which account for approximately one quarter of primary care attendances. The objective of C-reactive protein point-of-care testing (CRP POCT) is to assist the clinician in ruling out serious bacterial infection, thereby supporting a decision not to prescribe an antibiotic to those who are unlikely to benefit from treatment. HIQA’s health technology

2019 Health Information and Quality Authority

6. Understanding genetic tests for breast and ovarian cancer that runs in the family

Understanding genetic tests for breast and ovarian cancer that runs in the family Understanding genetic tests for breast and ovarian cancer that runs in the family Information and decision aidPublished May 2008 Reprinted January 2014 Current print February 2018 This booklet was developed and printed with the support of: Hereditary Cancer Clinic, Prince of Wales Hospital Macquarie University Centre for Genetics Education, NSW Health, Royal North Shore Hospital Cancer Council NSW Understanding (...) genetic tests for breast and ovarian cancer that runs in the family Information and decision aidWho is this booklet for? This booklet contains information for women who are considering genetic testing for breast and ovarian cancer that runs in their family. This information is not a replacement for discussing genetic testing with your doctor or family cancer services. Choose the sections that are relevant to you, coupled with information from your health professionals, to make an informed decision

2019 European Society of Endocrinology

7. Understanding genetic tests for Lynch syndrome

high-risk breast cancer families. European Journal of Cancer. 38(15):2025-2031. 8. Wakefield C, Kasparian N, Meiser B, et al. 2007. Attitudes toward genetic testing for cancer risk after genetic counseling and decision support: a qualitative comparison between hereditary cancer types. Genetic testing. 11(4):401-411. Thanks We would like to thank the following people for their invaluable assistance in the development of this booklet: Assoc Professor Kristine Barlow-Stewart, Ms Liz Drake, Ms Rebecca (...) Understanding genetic tests for Lynch syndrome Understanding genetic tests for Lynch syndrome Information and decision aidPrevious print: May 2008 Review and print: August 2010 Current print January 2014 This booklet was developed and printed with the support of: Hereditary Cancer Clinic, Prince of Wales Hospital Macquarie University Centre for Genetics Education, NSW Health, Royal North Shore Hospital Cancer Council NSW Who is this booklet for? This booklet is for anyone thinking about having

2019 European Society of Endocrinology

8. MammaPrint test for personalised management of adjuvant chemotherapy decisions in early breast cancer

MammaPrint test for personalised management of adjuvant chemotherapy decisions in early breast cancer 2018 www.kce.fgov.be KCE REPORT 298 MAMMAPRINT® TEST FOR PERSONALISED MANAGEMENT OF ADJUVANT CHEMOTHERAPY DECISIONS IN EARLY BREAST CANCER A RAPID ASSESSMENT 2018 www.kce.fgov.be KCE REPORT 298 HEALTH TECHNOLOGY ASSESSMENT MAMMAPRINT® TEST FOR PERSONALISED MANAGEMENT OF ADJUVANT CHEMOTHERAPY DECISIONS IN EARLY BREAST CANCER A RAPID ASSESSMENT LORENA SAN MIGUEL, CECILE DUBOIS, SOPHIE GERKENS (...) , JILLIAN HARRISON, FRANK HULSTAERT COLOPHON Title: MammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer Authors: Lorena San Miguel (KCE), Cécile Dubois (KCE), Sophie Gerkens (KCE), Jillian Harrison (KCE), Frank Hulstaert (KCE) Project coordinator: Nathalie Swartenbroeckx (KCE) Reviewers: Pascale Jonckheer (KCE), Mélanie Lefevre (KCE) External experts: Pino G. Cusumano (Kankercentrum – Centre du Cancer; WIV-ISP), Giuseppe Floris (UZ Leuven), Joris

2018 Belgian Health Care Knowledge Centre

9. Barlow's Test

Barlow's Test Barlows Test Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Barlow's Test Barlow's Test Aka: Barlow's Test , Barlow (...) Test , Barlow Maneuver II. Indication evaluation III. Mechanism Attempt to sublux unstable hip Perform with caution Examine each hip individually IV. Preparation Infant lying supine with diaper off Hips flexed to 90 degrees V. Technique Stabilize Place index and middle finger over greater trochanter Place thumb medially at inner thigh inguinal crease Gently adduct the hip while applying downward force VI. Findings Positive if felt on exam Represents dislocation of hip out of acetabulum Positive

2015 FP Notebook

10. AIM Clinical Appropriateness Guidelines for Molecular Testing of Solid and Hematologic Tumors and Malignancies

AIM Clinical Appropriateness Guidelines for Molecular Testing of Solid and Hematologic Tumors and Malignancies Appropriate.Safe.Affordable © 2017 AIM Specialty Health 2066-1217 Clinical Appropriateness Guidelines Molecular Testing of Solid and Hematologic Tumors and Malignancies EFFECTIVE DECEMBER 1, 2017 PROPRIETARY Guidelines developed by, and used with permission from, Informed Medical Decisions, Inc. © 2017 Informed Medical Decisions, Inc. All Rights Reserved. 2 Table of Contents Scope 3 (...) Tumor Testing 10 Breast Cancer 10 Lung Cancer 12 Cell-Free Tumor Testing 13 Cancer of Unknown Primary/Occult Neoplasm 14 Prostate Cancer 14 Thyroid Cancer 15 Cancer Screening 15 Indeterminate Thyroid Nodules 15 Colorectal Cancer Screening 16 Professional Society Guidelines 18 Selected References 19 Revision History 20 PROPRIETARY Guidelines developed by, and used with permission from, Informed Medical Decisions, Inc. © 2017 Informed Medical Decisions, Inc. All Rights Reserved. 3 Scope This document

2017 AIM Specialty Health

11. Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: A systematic review and quality appraisal

Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: A systematic review and quality appraisal The Hospital for Sick Children Technology Assessment at SickKids (TASK) FULL REPORT THIOPURINE S-METHYLTRANSFERASE TESTING FOR AVERTING DRUG TOXICITY IN PATIENTS RECEIVING THIOPURINES: A SYSTEMATIC REVIEW AND QUALITY APPRAISAL Authors: Lilla M. Roy, RN, BScN, MSc Clinical Research Project Coordinator, Child Health Evaluative Services, The Hospital (...) and phenotype testing, and Cathy Pajunen for her library services and referencing technical support. CONFLICTS OF INTEREST The authors have no conflicts of interest to disclose.iii TABLE OF CONTENTS LIST OF TABLES v LIST OF FIGURES vi 1 INTRODUCTION 1 1.1 Objectives 3 2 METHODS 4 2.1 Systematic review 4 2.1.1 Inclusion and exclusion criteria 4 2.1.2 Literature search design 5 2.1.2.1 Search sources 5 2.1.2.2 Search term selection and development of search strategies 6 2.1.2.3 Search permutations 8 2.1.2.4

2015 SickKids Reports

12. Do evidence-based interventions work when tested in the "real world?" A systematic review and meta-analysis of parent management training for the treatment of child disruptive behavior

were already collected as part of routine practice. Funding Not stated. Bibliographic details Michelson D, Davenport C, Dretzke J, Barlow J, Day C. Do evidence-based interventions work when tested in the "real world?" A systematic review and meta-analysis of parent management training for the treatment of child disruptive behavior. Clinical Child and Family Psychology Review 2013; 16(1): 18-34 PubMedID DOI Original Paper URL Indexing Status Subject indexing assigned by NLM MeSH Adult; Child; Child (...) Do evidence-based interventions work when tested in the "real world?" A systematic review and meta-analysis of parent management training for the treatment of child disruptive behavior Do evidence-based interventions work when tested in the "real world?" A systematic review and meta-analysis of parent management training for the treatment of child disruptive behavior Do evidence-based interventions work when tested in the "real world?" A systematic review and meta-analysis of parent management

2013 DARE.

13. Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer

of the analysis, the authors’ conclusions appear to be valid. Funding No external funding was received. Bibliographic details Hall PS, McCabe C, Stein RC, Cameron D. Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer. Journal of the National Cancer Institute 2012; 104(1): 56-66 PubMedID DOI Original Paper URL Other publications of related interest Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh IT, Ravdin P, Bugarini R, Baehner FL (...) Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer Hall PS, McCabe C, Stein RC, Cameron D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract

Full Text available with Trip Pro

2012 NHS Economic Evaluation Database.

14. Test of an Inhibitory Learning Model of Extinction in Treatment of Anxious Youth

Test of an Inhibitory Learning Model of Extinction in Treatment of Anxious Youth Test of an Inhibitory Learning Model of Extinction in Treatment of Anxious Youth - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Test of an Inhibitory Learning Model of Extinction in Treatment of Anxious Youth The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03372915 Recruitment Status : Recruiting First Posted : December 14, 2017 Last Update

2017 Clinical Trials

15. Exercise Standards for Testing and Training

Exercise Standards for Testing and Training Exercise Standards for Testing and Training | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free (...) Access article Exercise Standards for Testing and Training A Scientific Statement From the American Heart Association , MD, FAHA, Chair , MD, Co-Chair , MD, FAHA, Co-Chair , PhD, PT, FAHA , MD, FAHA , MD, MSPH, FAHA , PhD, ACNS, FAHA , MD , MD, FAHA , MD, PhD, FAHA , MD, MS, FAHA , PhD, PT , MD , and MD PhDon behalf of the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism

2013 American Heart Association

16. Friedman Test in Hydatidiform Mole and Chorion Epithelioma (PubMed)

Friedman Test in Hydatidiform Mole and Chorion Epithelioma 20780405 2011 03 31 2011 03 31 0007-1447 1 3966 1937 Jan 09 British medical journal Br Med J Friedman Test in Hydatidiform Mole and Chorion Epithelioma. 71-2 Lazarus-Barlow P P eng Journal Article England Br Med J 0372673 0007-1447 2010 8 27 6 0 1937 1 9 0 0 1937 1 9 0 1 ppublish 20780405 PMC2087969

Full Text available with Trip Pro

1937 British medical journal

17. Obesity in children

percentile is defined as severe obesity. Barlow SE. Expert Committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007 Dec;120(suppl 4):S164-92. http://pediatrics.aappublications.org/content/120/Supplement_4/S164.full http://www.ncbi.nlm.nih.gov/pubmed/18055651?tool=bestpractice.com Canoy D, Bundred P. Obesity in children. BMJ Clin Evid. 2011 Apr 4;2011. pii: 0325. http://www.ncbi.nlm.nih.gov/pmc/articles (...) /PMC3217765/ http://www.ncbi.nlm.nih.gov/pubmed/21463538?tool=bestpractice.com For children under 2 years of age, BMI percentiles are not available; thus, obesity may be defined as a weight ≥95th percentile for height. Barlow SE. Expert Committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007 Dec;120(suppl 4):S164-92. http://pediatrics.aappublications.org/content/120/Supplement_4/S164.full http

2019 BMJ Best Practice

18. The efficacy of post-exposure prophylaxis (PEP) for HIV

considered potential PEP failures, as they tested HIV positive at two and five months following PEP, respectively. One additional patient tested negative at his baseline visit and at 11 days following the completion of PEP, but tested HIV positive at five months — indicating another potential PEP failure. The fourth case was considered unlikely to be a PEP failure, as they tested HIV negative as late as one year after receiving PEP (15). The third study found that 649 individuals enrolled in the Los (...) at a sexual health service in London, UK (17). The specific PEP regimen was not recorded. During this period 530 individuals received PEP. Of them, 183 received more than one course. The number of seroconversions was 57, resulting in an HIV incidence of 7.6 per 100 person-years. Of those who seroconverted, 40 individuals had negative HIV tests following their PEP course, and prior to diagnosis. Another five received a positive diagnosis more than two months following their initiation of PEP

2019 Ontario HIV Treatment Network

19. Sexualized drug use (chemsex and methamphetamine) and men who have sex with men

domains including psychomotor, working memory, attention, cognitive control, and decision making (52). Another systematic review found that delusions, auditory and visual hallucinations, hostility, depression, and conceptual disorganization are central to methamphetamine-associated psychosis (4). A retrospective review of emergency department patients (n= 113,015) over a two-year period in California found that individuals who tested positive for methamphetamine in their toxicology screen (n=4,407 (...) . systematic review team concluded its literature search (October 2017). However, earlier versions of these interventions were included in the Knight et al. review. They are discussed below. Project Tech Support , published in 2012, was a pilot study (77) that tested the feasibility and utility of a text-messaging intervention to reduce methamphetamine use and high-risk sexual behaviours among men who have sex with men. Participants (n=52) received real-time health education text messages and social

2019 Ontario HIV Treatment Network

20. Follow-Up Model of Care for Cancer Survivors: Recommendations for the Delivery of Follow-up Care for Cancer Survivors in Ontario

. In 2016, Cancer Care Ontario and the Institute for Clinical Evaluative Studies conducted a study that examined the impact of this follow-up model of care. This study showed that, when compared to a matched control cohort, transitioning breast cancer survivors to primary care was associated with more appropriate use of healthcare services, lower healthcare cost per survivor, and higher rate of appropriate surveillance tests such as mammography. 4 The study also found that while the number of specialist (...) advanced training in a specific area of medicine (e.g., oncology, urology, hematology, and surgery). 10 • Most responsible provider (MRP): The MRP is a regulated healthcare professional (e.g., physician, nurse practitioner) who is responsible for directing and coordinating care for survivors. Their role includes, but are not limited to, ordering surveillance tests, prescribing medications, assessing needs for and coordinating supportive care, and updating the follow-up care plan. 11 Guiding Principles

2019 Cancer Care Ontario

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>